Advertisement

Journal of Urban Health

, Volume 78, Issue 2, pp 256–263 | Cite as

HIV and AIDS surveillance among inmates in Maryland prisons

  • Edward N. KassiraEmail author
  • Robert L. Bauserman
  • Naomi Tomoyasu
  • Ellen Caldeira
  • Anthony Swetz
  • Liza Solomon
Special Feature: Continuity of Care from Corrections to Community

Abstract

The prevalence of those with human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS) is higher among inmates of correctional facilities than among the general population. This raises the need to identify inmates living with or at risk of HIV/AIDS and to provide counseling and appropriate survices for HIV treatment and prevention. The Maryland Division of Corrections (DOC) offers voluntary testing to all inmates on entry and tests inmates when clinically indicated. We reviewed all 1998 HIV antibody tests and confirmed AIDS cases in the Maryland DOC. Inmate demographics, testing acceptance, rates of seropositivity, and AIDS cases and comparisons based on gender, racelethnicity, and age were examined. Comparisons were also made to HIV testing and AIDS cases from the nonincarcerated Maryland population. Trends in DOC AIDS diagnoses and AIDS-related deaths over time were also examined. Of the inmates, 39% were voluntarily tested for HIV on entry to the Maryland DOC in 1998 (38% of males and 49% of females). Overall, HIV seropositivity was 33% (5% for females and 3% for males). The 888 cumulative AIDS cases diagnosed in the DOC inmate population were concentrated among males (90% vs. 77% statewide), African Americans (91% vs. 75% statevide), and among IDUs (84% vs. 39% statewide). Due to high rates of HIV and AIDS, inmate populations are a crucial audience for HIV/AIDS testing, treatment, and prevention efforts, especially women. Prison-based programs can identify significant numbers of HIV and AIDS cases and bring HIV prevention interventions to a population characterized by frequent high-risk behavior.

Keywords

Human Immunodeficiency Virus Human Immunodeficiency Virus Infection Human Immunodeficiency Virus Prevention Prison Population Correctional Facility 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Maruschak L.HIV in Prisons 1997. Washington, DC: US Dept of Justice; November 1999. Bureau of Justice Statistics Bulletin publication NCJ 178284.Google Scholar
  2. 2.
    US Department of Justice, Office of Justice Programs, Bureau of Justice Statistics.Prison and Jail Inmates at Midyear 1996: Washington, DC: US Dept of Justice; January 1997. Publication NCJ-162843.Google Scholar
  3. 3.
    Hammett T, Widom R, Epestein J, et al.1994 Update: HIV/AIDS and STDs in Correctional Facilities. Washington DC: Office of Justice Programs, National Institute of Justice/Dept of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention; December 1995.Google Scholar
  4. 4.
    Dean-Gaitor HD, Fleming PL. Epidemiology of AIDS in incarcerated persons in the United States, 1994–1996.AIDS 1999;13:2429–2435.CrossRefPubMedGoogle Scholar
  5. 5.
    Centers for Disease Control and Prevention.HIV/AIDS Surveillance Report. Atlanta, GA: Centers for Disease Control and Prevention; 1998:10(2):8.Google Scholar
  6. 6.
    Maryland AIDS Epidemiological Profile,Maryland HIV/AIDS Update. Baltimore, MD: AIDS Administration, Department of Health and Mental Hygiene; Springer 2000:7–8.Google Scholar
  7. 7.
    Gilliard DK, Beck AJ.Prison and Jail Inmates, 1995. Washington, DC: US Dept of Justice; August 1996. Bureau of Justice Statistics Bulletin publication NCJ-161132.Google Scholar
  8. 8.
    Maryland HIV Epidemiological Profile.Maryland HIV/AIDS Update. Baltimore, MD: AIDS Administration, Department of Health and Mental Hygiene; Summer 2000:3–4.Google Scholar
  9. 9.
    St. Lawrence JS, Eldridge GD, Shelby MC, et al. HIV risk reduction for incarcerated women: a comparison of brief interventions based on two theoretical models.J Consult Clin Psychol. 1997;65:504–509.CrossRefPubMedGoogle Scholar
  10. 10.
    St. Lawrence JS, Crosby RA, Belcher L, et al. Sexual risk reduction and anger management interventions for incarcerated male adolescents: a randomized controlled trial of two interventions.J Sex Educ Ther. 1999;24:9–17.Google Scholar
  11. 11.
    Mikl J, Dzierbicki A, Smith PF, Griefinger R, Wright L, Morse DL.Trends in HIV Infection Among New York State Prison Entrants, 1987–97. International Conference on AIDS 1998, 12:445. Abstract 23516.Google Scholar
  12. 12.
    Behrendt C, Kendig N, Dambita C, Horman J, Lawlor J, Vlahov D. Voluntary testing for human immunodeficiency virus (HIV) in a prison population with a high prevalence of HIV.Am J Epidemiol. 1994;139:918–926.PubMedGoogle Scholar
  13. 13.
    Flynn C, Landrigan J, Sitakis F, Caldeira E.The 1999 Maryland Annual HIV/AIDS Report. Baltimore, MD: AIDS Administration, Department of Health and Mental Hygiene; 16.Google Scholar
  14. 14.
    Weirsema J, Richardson DA.Program Implementation's Effects on HIV/AIDS Prevention Program Outcome in Maryland Prisons and Jails. National HIV Prevention Conference 1999; August 29–September 1, 1999; Atlanta, GA. Abstract 402.Google Scholar

Copyright information

© The New York Academy of Medicine 2001

Authors and Affiliations

  • Edward N. Kassira
    • 1
    Email author
  • Robert L. Bauserman
    • 1
  • Naomi Tomoyasu
    • 1
  • Ellen Caldeira
    • 1
  • Anthony Swetz
    • 2
  • Liza Solomon
    • 1
  1. 1.Department of Health and Mental HygieneAIDS AdministrationBaltimore, MD
  2. 2.Department of CorrectionsOffice of Inmate Health CareBaltimore, MD

Personalised recommendations